Monday, September 6, 2021

#1 Stock and ETF List To Consider This Morning

Tiny Biotech Creates $2 Trillion Drug
The Wall Street Journal reports new treatment is "transforming medicine." Bill Gates writes that it could "help humanity." Ark Investments think it could be a "$2 trillion market."  And one small company owns the patent on it. (ad)
This unknown biotech's stock is set to surge 46,751% >>>

Symbol Last ST Trend Signal St. Rank
LODE Comstock Mining Inc $3.23 Up Buy 91
APPS Digital Turbine $63.89 Up Buy 90
CLMT Calumet Specialty Pr $6.89 Up Buy 90
OSS One Stop Systems Inc $5.96 Up Buy 88
MVO Mv Oil Trust $7.10 Up Buy 88
Symbol Last ST Trend Signal St. Rank
IAU Gold Trust Ishares $34.82 Up Buy 98
MLPX Global X MLP & Energy Infrastructure ETF $34.76 Up Buy 80
FTGC Global Tactical Commodity Strategy Fund FT $24.00 Up Buy 77

Five Stocks to Watch During the Cryptocurrency BoomAs cryptocurrencies start to dip, the stocks that surround the groundbreaking currency are poised for growth. Now, this exclusive report guides you to stocks that have exposure to this brand new market. (ad)
There may be no better time to add these 5 cryptocurrency stocks to your watchlist.

Already subscribed to our premium service?

Not a TradersPro subscriber yet?







This email was sent to edwardlorilla1986.paxforex@blogger.com
from Investiv, LLC
265 N. Main | Ste. D #283
Kaysville | UT | 84037

Unsubscribe
Disclaimers, Terms & Conditions

Privacy Policy

Copyright 2021

Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.

No comments:

Post a Comment